SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-025155
Filing Date
2021-05-07
Accepted
2021-05-06 18:01:18
Documents
74
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stro-10q_20210331.htm   iXBRL 10-Q 2825825
2 EX-10.1 stro-ex101_9.htm EX-10.1 95384
3 EX-31.1 stro-ex311_8.htm EX-31.1 17662
4 EX-31.2 stro-ex312_6.htm EX-31.2 16894
5 EX-32.1 stro-ex321_10.htm EX-32.1 6607
6 EX-32.2 stro-ex322_7.htm EX-32.2 6635
  Complete submission text file 0001564590-21-025155.txt   9924057

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA stro-20210331.xsd EX-101.SCH 76741
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stro-20210331_cal.xml EX-101.CAL 41359
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stro-20210331_def.xml EX-101.DEF 261161
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20210331_lab.xml EX-101.LAB 532237
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20210331_pre.xml EX-101.PRE 406392
12 EXTRACTED XBRL INSTANCE DOCUMENT stro-10q_20210331_htm.xml XML 1754712
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 21899384
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences